Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Atterhög J. H., Dunér H., Pernow B. Haemodynamic effects of pindolol in hypertensive patients. Acta Med Scand Suppl. 1977;606:55–62. doi: 10.1111/j.0954-6820.1977.tb18030.x. [DOI] [PubMed] [Google Scholar]
- Brogden R. N., Heel R. C., Speight T. M., Avery G. S. Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs. 1978 Apr;15(4):251–270. doi: 10.2165/00003495-197815040-00002. [DOI] [PubMed] [Google Scholar]
- Koch G. Acute hemodynamic effects of an alpha- and beta-receptor blocking agent (AH 5158) on the systemic and pulmonary circulation at rest and during exercise in hypertensive patients. Am Heart J. 1977 May;93(5):585–591. doi: 10.1016/s0002-8703(77)80008-2. [DOI] [PubMed] [Google Scholar]
- Koch G. Combined alpha- and beta-adrenoreceptors blockade with oral labetalol in hypertensive patients with reference to haemodynamic effects at rest and during exercise. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):729–732. [PubMed] [Google Scholar]
- Koch G. Haemodynamic adaptation at rest and during exercise to long-term antihypertensive treatment with combination of beta-receptor blocking and vasodilator agent. Br Heart J. 1976 Dec;38(12):1240–1246. doi: 10.1136/hrt.38.12.1240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koch G. Haemodynamic effects of combined alpha- and beta-adrenoreceptor blockade after intravenous labetalol in hypertensive patients at rest and during exercise. Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):725–728. [PubMed] [Google Scholar]
- Koch G. Hemodynamic effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) at rest and during exercise with special respect to the pulmonary circulation. Arzneimittelforschung. 1971 Jan;21(1):57–61. [PubMed] [Google Scholar]
- Lund-Johansen P., Ohm O. J. Haemodynamic long-term effects of beta-receptor-blocking agents in hypertension: a comparison between alprenolol, atenolol, metoprolol and timolol. Clin Sci Mol Med Suppl. 1976 Dec;3:481S–483S. doi: 10.1042/cs051481s. [DOI] [PubMed] [Google Scholar]
- Majid P. A., Meeran M. K., Benaim M. E., Sharma B., Taylor S. H. Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension. Br Heart J. 1974 Jun;36(6):588–596. doi: 10.1136/hrt.36.6.588. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tarazi R. C., Dustan H. P. Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations. Am J Cardiol. 1972 May;29(5):633–640. doi: 10.1016/0002-9149(72)90164-6. [DOI] [PubMed] [Google Scholar]
- Weiss L., Lundgren Y., Folkow B. Effects of prolonged treatment with adrenergic beta-receptor antagonists on blood pressure, cardiovascular design and reactivity in spontaneously hypertensive rats (SHR). Acta Physiol Scand. 1974 Aug;91(4):447–457. doi: 10.1111/j.1748-1716.1974.tb05701.x. [DOI] [PubMed] [Google Scholar]